Iopamidol interference in protein separation by capillary electrophoresis and its connection to renal function
Abstract
Introduction: Interferences in the electrophoretic proteinogram by capillary electrophoresis include the appearance of peaks with concentrations and electrophoretic mobilities, which could simulate the presence of a monoclonal component. Objectives: In the light of an additional peak with interα2-β mobility by capillary electrophoresis (MINICAP®-Sebia), the aim was to identify the interferent and evaluate its connection to renal functionality. Methods: Serum samples that presented this interference over a period of one year were studied by proteinogram on solid support, electroimmunofixation and immunoelectrophoresis. The probable interferent was added in vitro to confirm its electrophoretic mobility. The impact of the interference correction with the “artifact removal” tool (Phoresis®-Sebia) and the correlation of the baseline peak concentration of the interferent with the estimation of the glomerular filtration rate (CKD-EPI) were evaluated. Results: The integration to the baseline of the peaks was 0.07-0.36 g/dL. No particularities were observed when performing the complementary studies. In all cases, the administration of Iopamidol as a contrast medium was demonstrated, confirming its electrophoretic mobility due to its in vitro addition. Using the “artifact removal” tool, the basal levels of the fractions were recovered. The existence of a correlation between the concentration of the baseline peak of the interferent and the estimation of the glomerular filtration rate by CKD-EPI was shown (r=-0.534, p <0.0001). Conclusions: The interferent was identified as Iopamidol and its connection to the decrease in the glomerular filtration rate was demonstrated.
References
Keren DF, Humphrey RL. Clinical indications and applications of serum and urine protein electrophoresis. En: Manual of molecular and clinical laboratory immunology. Edited by Barbara Detrick, John L. Schmitz and Robert G. Hamilton. 8th ed. Washington, DC: ASM Press, 2016. Chap. 8.
Keren DF, Schroeder L. Challenges of measuring monoclonal proteins in serum. Clin Chem Lab Med. 2016;54(6):947-61.
Bossuyt X, Mewis A, Blanckaert N. Interference of radio-opaque agents in clinical capillary zone electrophoresis. Clin Chem. 1999;45(1):129-31.
Arranz-Peña ML, González-Sagrado M, Olmos-Linares AM, Fernández-García N, Martín-Gil FJ. Interference of iodinated contrast media in serum capillary zone electrophoresis. Clin Chem. 2000;46(5):736-7.
Bossuyt X. Separation of serum proteins by automated capillary zone electrophoresis. Clin Chem Lab Med. 2003;41(6):762-72.
Bossuyt X. Interferences in clinical capillary zone electrophoresis of serum proteins. Electrophoresis. 2004;25(10-11):1485-7.
Jin Park Y, Hoon Rim J, Yim J, Lee S-G, Kim J-H. Effects of two types of medical contrast media on routine chemistry results by three automated chemistry analyzers. Clin Biochem. 2017; 50(12):719-25.
van der Watt G, Berman W. Pseudoparaproteinemia after iopamidol infusion for coronary angiography. Clin Chem. 2005,51(1):273-4.
Siede D, Möller H, Siede WH, Regeniter A. Effect of ampicillin-sulbactam on clinical capillary zone electrophoresis of serum proteins. Clin Chem Lab Med. 2008;46(10):1468-9.
Bossuyt X, Peetermans WE. Effect of piperacillin-tazobactam on clinical capillary zone electrophoresis of serum proteins. Clin Chem. 2002;48(1):204-5.
Bossuyt X, Verhaegen J, Mariën G, Blanckaert N. Effect of sulfamethoxazole on clinical capillary zone electrophoresis of serum proteins. Clin Chem. 2003;49(2):340-1.
Vermeersch P, Mariën G, Bossuyt X. Pseudoparaproteinemia related to iomeprol administration after angiocardiography: Detection in the beta fraction by capillary zone electrophoresis. Clin Chem. 2006;52(12):2312-3.
Samson E, Allouche S. Iohexol interference in the α2-globulin fraction of the serum protein capillary electrophoresis. Clin Chem Lab Med. 2015;53(12):e337-8.
García MD, Madalena LB, Bragantini GC, Bresciani PD, Pizzolato MA. Electroinmunofijación de orinas sin concentrar por coloración con metales pesados. Acta Bioquím Clín Latinoam. 1996;30(3):215-20.
Lorusso V, Taroni P, Alvino S, Spinazzi A. Pharmacokinetics and safety of iomeprol in healthy volunteers and in patients with renal impairment or end-stage renal disease requiring hemodialysis. Invest Radiol. 2001;36(6):309-16.
Carballo Silva L, Carballeira Pol L, Calvo Comella M, Rentería Obregón I, García-Moll X, Martínez- Brú C. Interferencias por contrastes yodados en la electroforesis capilar. Rev Lab Clín. 2010;3(3):129-35.
Cho SY, Kim Y, Anbok Lee, Park TS, Lee HJ, Suh JT. Three cases showing false results in the detection of monoclonal components using capillary electrophoresis. Lab Med. 2011;42(10):602-6.
Katzmann JA, Stankowski-Drengler TJ, Kyle RA, Karen SL, Snyder MR, Lust JA, et al. Specificity of serum and urine protein electrophoresis for the diagnosis of monoclonal gammopathies. Clin Chem. 2010;56(12):1899-900.
Rajkumar SV. Updated Diagnostic Criteria and Staging System for Multiple Myeloma. Am Soc Clin Oncol Educ Book. 2016;35:e418-23.
